Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01061216
What this trial is testing

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 20
Testing effectiveness (Phase 2)Study completedNCT06007430
What this trial is testing

Colostrum Supplements Effect on the Physical Performance and Cognitive Function

Who this might be right for
Diabetes Mellitus, Type 2
Al-Mustafa University College 80
Early research (Phase 1)Study completedNCT05576298
What this trial is testing

A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 46
Testing effectiveness (Phase 2)Study completedNCT03449199
What this trial is testing

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Who this might be right for
Diabetic Kidney Disease
Teijin America, Inc. 130
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Large-scale testing (Phase 3)Ended earlyNCT01549964
What this trial is testing

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

Who this might be right for
Glycemic Control
Takeda 916
Post-approval studies (Phase 4)Study completedNCT00807092
What this trial is testing

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Not applicableStudy completedNCT00659711
What this trial is testing

The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects

Who this might be right for
Type 2 Diabetes
University at Buffalo 22
Not applicableStudy completedNCT00977262
What this trial is testing

Postprandial Inflammation and Fatty Acids

Who this might be right for
Cardiovascular DiseaseDiabetes Type 2Obesity
Wageningen University 42
Early research (Phase 1)Study completedNCT00625859
What this trial is testing

Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 27
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Post-approval studies (Phase 4)Study completedNCT01390480
What this trial is testing

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 31
Post-approval studies (Phase 4)Study completedNCT00568074
What this trial is testing

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 131
Large-scale testing (Phase 3)Study completedNCT00097279
What this trial is testing

Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 230
Early research (Phase 1)Study completedNCT01464099
What this trial is testing

Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 24
Post-approval studies (Phase 4)Study completedNCT00469092
What this trial is testing

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 480
Early research (Phase 1)Study completedNCT01798264
What this trial is testing

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Intarcia Therapeutics 44
Post-approval studies (Phase 4)Study completedNCT01465152
What this trial is testing

Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 182
Not applicableStudy completedNCT01572402
What this trial is testing

Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects

Who this might be right for
Type 2 DiabetesPostprandial Oxidative Stress
Institute for Clinical and Experimental Medicine 100
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation